Vieira Luís, Martinho Ana, Antunes Ofélia, Silva Elizabeth, Ambrósio Ana P, Geraldes Maria C, Nascimento Rute, Silva Cândido, Pereira José M, Júnior Esmeraldina C, Jordan Peter
Centro de Genética Humana, Instituto Nacional de Saúde Dr Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisboa, Portugal.
Diagn Mol Pathol. 2008 Jun;17(2):73-81. doi: 10.1097/PDM.0b013e31814be9e0.
Translocations t(14;18)(q32;q21) and t(11;14)(q13;q32) are recurrent findings in follicular lymphoma (FL) and mantle cell lymphoma (MCL), respectively. However, the molecular counterparts of these translocations can only be detected in up to 75% of FL and 50% of MCL cases using routine techniques. To improve the efficiency of detection, we first devised a single-tube multiplex-polymerase chain reaction (PCR) assay with primers located within a conserved immunoglobulin heavy chain (IGH) sequence and 5' to the main breakpoint cluster regions of BCL2 and CCND1. Using this assay in 17 FL and 11 MCL diagnostic DNA samples, we readily identified a BCL2-IGH fusion in 65% of FL patients and a CCND1-IGH fusion in 55% of MCL patients. In the remaining cases, we used long distance inverse-PCR to detect BCL2-IGH and CCND1-IGH fusion genes with different BCL2 and CCND1 breakpoint locations. We found additional translocations in 3 patients (17%) with FL and in 4 patients (36%) with MCL. Taken together, we show that multiplex-PCR combined with long distance inverse-PCR detected a t(14;18) in 82% of FL patients and a t(11;14) in 91% of MCL patients, demonstrating that this 2-step protocol is an effective approach for molecular detection of t(11;14) and t(14;18) in B-cell lymphomas.
易位t(14;18)(q32;q21)和t(11;14)(q13;q32)分别是滤泡性淋巴瘤(FL)和套细胞淋巴瘤(MCL)中常见的发现。然而,使用常规技术,这些易位的分子对应物仅能在高达75%的FL病例和50%的MCL病例中检测到。为了提高检测效率,我们首先设计了一种单管多重聚合酶链反应(PCR)检测方法,其引物位于保守的免疫球蛋白重链(IGH)序列内以及BCL2和CCND1主要断点簇区域的5'端。在17份FL和11份MCL诊断DNA样本中使用该检测方法,我们轻松地在65%的FL患者中鉴定出BCL2-IGH融合,在55%的MCL患者中鉴定出CCND1-IGH融合。在其余病例中,我们使用长距离反向PCR来检测具有不同BCL2和CCND1断点位置的BCL2-IGH和CCND1-IGH融合基因。我们在3例(1